Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Skin Cancer Channel is supported with funding from Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ESSO 45 | Why prospective evidence is needed to define the role of melanoma re-excision

Joanna Amkreutz, MD, PhD, Leiden University Medical Center, Leiden, Netherlands, presents findings demonstrating substantial variation in clinical practice regarding re-excision for melanoma, with physicians differing in how they measure margins, determine excision depth, and adhere to established guidelines. Despite re-excision being standard care for melanoma for decades, the procedure lacks standardization, professional consensus, and robust supporting evidence. Therefore, prospective evidence is urgently needed to define the role of re-excision in future melanoma management. This interview took place at the 2026 European Society of Surgical Oncology (ESSO) Annual Meeting in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Yes, so actually our main finding is that there’s large variation in the clinical practice of re-incision. So we observed that physicians differ in how they measure, for example, the margins for re-excision, how deep they excise for re excision, but also to what extent they adhere to the guideline and in which scenarios they choose to deviate from those guidelines. so the implications of our study are actually that despite re-excision being standard care for melanoma for decades, it still lacks standardization and professional consensus and also it lacks reviews supporting evidence...

Yes, so actually our main finding is that there’s large variation in the clinical practice of re-incision. So we observed that physicians differ in how they measure, for example, the margins for re-excision, how deep they excise for re excision, but also to what extent they adhere to the guideline and in which scenarios they choose to deviate from those guidelines. so the implications of our study are actually that despite re-excision being standard care for melanoma for decades, it still lacks standardization and professional consensus and also it lacks reviews supporting evidence. So we think that there’s a high need for more evidence, more prospective evidence, to define its role in future melanoma care.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.